Our mission is to provide more effective and globally reaching treatment solutions for patients at risk of vision loss and blindness by developing orally administered therapies for patients with deteriorating vision from retinal vascular diseases within ophthalmology.
With a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD), we are developing novel oral therapies to address very large unmet needs and meet physicians’ requests for more effective treatments, earlier intervention and with less burden on patients to improve outcomes.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Very Large Unmet Needs And Meet Physicians’ Requests For More Effective Treatments
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.breye.com
Breye Therapeutics Aps Questions
Breye Therapeutics Aps's website is http://www.breye.com
Breye Therapeutics Aps's LinkedIn profile is https://www.linkedin.com/company/breye-therapeutics-aps
Breye Therapeutics Aps has
10 employees.
View email and phone details for 10
employees at Breye Therapeutics Aps.
Breye Therapeutics Aps's industry is
Pharmaceutical Manufacturing
Breye Therapeutics Aps's top competitors are
Again,
Kariya Pharmaceuticals,
Hyme,
Oxurion Nv,
Boost Pharma,
Lophora,
Muna Therapeutics,
Eyebio,
Rewind Therapeutics,
Golgi Neurosciences S.r.l..
Breye Therapeutics Aps's categories are Pharmaceutical Manufacturing
Breye Therapeutics Aps's founding year is 2019
